MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for orphan diseases, with an initial focus on cardiopulmonary disorders, announced the appointment of Edmund P. Harrigan, M.D. to its board of directors, effective December 13, 2018.
Dr. Harrigan brings nearly three decades of experience in the pharmaceutical industry to PhaseBio’s board. During his 18-year tenure with Pfizer, Dr. Harrigan held numerous leadership roles in business development, regulatory affairs and quality assurance, most recently serving as Senior Vice President of Worldwide Safety and Regulatory, where he led global safety and regulatory organizations. From 2010 to 2012, he served as President and Chief Executive Officer of Karuna Pharmaceuticals. Earlier in his career, Dr. Harrigan held leadership roles at Neurogen Corporation and Sepracor (now Sunovion Pharmaceuticals). Dr. Harrigan began his career as a practicing neurologist and was the co-founder of Coastal Neurology Services.
“We are thrilled to welcome Ed to our board of directors,” said Jonathan P. Mow, Chief Executive Officer of PhaseBio. “We will benefit greatly from Ed’s significant pharmaceutical experience in global research and development, regulatory affairs and business development as we continue to execute on corporate milestones and advance PB2452 and PB1046 through clinical trials.”
Dr. Harrigan also serves on the boards of directors of Bellicum Pharmaceuticals, Karuna Pharmaceuticals, ACADIA Pharmaceuticals and Lyndra Therapeutics. He holds an M.D. from the University of Massachusetts Medical School and a B.A. in chemistry from Saint Anselm College.
“PhaseBio is rapidly progressing product candidates through the clinic and building a portfolio of important medicines to address orphan disease areas of high unmet medical need,” said Dr. Harrigan. “I look forward to working with the PhaseBio leadership team during this exciting time of corporate growth.”
Source: PhaseBio Pharmaceuticals, Inc., One Great Valley Parkway, Suite 30, Malvern PA 19355
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.